LYY5:XETRA:XETRA-Lyxor MSCI Europe (DR) UCITS ETF Acc (EUR)

ETF | Others |

Last Closing

USD 195.24

Change

+1.14 (+0.59)%

Market Cap

USD 0.80B

Volume

101.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.26 (+0.50%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.45%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.38 (+1.37%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.13 (+0.46%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.15 (+0.58%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.25 (+0.53%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.52 (+0.36%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.25 (+0.48%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.72 (+1.64%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.86 (+0.30%)

USD 80.38B

ETFs Containing LYY5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.04% 85% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.04% 85% B 81% B-
Trailing 12 Months  
Capital Gain 12.87% 54% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.87% 52% F 54% F
Trailing 5 Years  
Capital Gain 44.77% 64% D 66% D+
Dividend Return 1.64% 3% F 3% F
Total Return 46.41% 62% D 63% D
Average Annual (5 Year Horizon)  
Capital Gain 11.95% 71% C- 70% C-
Dividend Return 11.95% 70% C- 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.01% 53% F 62% D
Risk Adjusted Return 99.51% 87% B+ 88% B+
Market Capitalization 0.80B 73% C 65% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike